AstraZeneca says its COVID-19 vaccine is 79 percent effective in a U.S. trial

Worth one's salt: An ancient Maya commodity

Long-haul COVID: Columbia physicians review what's known

New Barrett's esophagus monitoring method could aid in easier and more precise prognoses